CAMPBELL, CA — NuVera Medical, Inc., a portfolio company of Shifamed, LLC., announced today it has raised $11M in Series A financing. The financing, which closed on June 28, 2017, was led by The Capital Partnership with participation from GE Ventures, Lilly Asia Ventures, and Cormorant Asset Management.

NuVera is a privately held company focused on the development of a next generation imaging platform for use in complex cardiovascular procedures. Concurrent with the close of the financing, NuVera entered into an exclusive agreement with GE for the license and supply of certain GE technology and products to be used in the NuVera platform.

Effective July 28th, NuVera also welcomed Todor Jeliaskov as fulltime President and CEO. Mr. Jeliaskov was previously Vice President of Global Ultrasound at GE Healthcare where he led the worldwide diagnostic ultrasound probes business. “I am honored to join the NuVera Medical team and welcome the opportunity to continue the work of Shifamed and GE Ventures in further developing this exciting platform,” said Mr. Jeliaskov. “The interventional market is rapidly evolving, and we, at NuVera, feel privileged to be on the forefront of innovation designed to meet the changing needs of the medical community.”

NuVera is the most recent addition to the Shifamed family of portfolio companies.

About NuVera Medical
NuVera Medical is a privately held medical device company formed by Shifamed LLC, a Silicon Valley based medical device incubator.

About Shifamed LLC
Founded by serial entrepreneur Amr Salahieh, Shifamed LLC is a privately held medical technology incubator focused on developing new medical products from concept to commercial release. To learn more about Shifamed, please visit www.shifamed.com.

MEDIA CONTACT:
Katie Arnold
SPRIG Consulting LLC
(408) 805-0520
katie@sprigconsulting.com